NCM · Financial Statements
Advanced Biomed Inc. (ADVB) Financial Statements
$5.31
NCM: ADVB
Market Cap $7.34M
Overview Financials Dividend Advanced Biomed Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-2.0M $-2.0M $0 $-3.0M $0 Net Profit $-2.0M $-4.0M $0 $-3.0M $0 EPS $-0.06 $-0.13 $-0.11 $-0.08 $-0.09 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $1.0M $7.0M $5.0M $4.0M $7.0M Total Liabilities $0 $3.0M $3.0M $3.0M $3.0M Cash $0 $5.0M $3.0M $3.0M $3.0M Borrowings $0 $0 $0 $0 $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $0 $-1.0M $-3.0M $-2.0M $0 Investing Cash Flow $0 $-2.0M $0 $0 $0 Financing Cash Flow $0 $0 $-1.0M $0 $0 Net Cash Flow $0 $5.0M $-2.0M $0 $0 Free Cash Flow $0 $-2.0M $-3.0M $-2.0M $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.04 EV / EBITDA -6.84 FCF Yield -7.93% Quick Ratio 7.38 Interest Coverage -9783.79 Return 1Y -67.50% Return 3Y — Return 5Y —
Screens featuring this stock